Life Science Analytics Market by Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics), Application (Research & Development, Clinical Trials, Sales & Marketing, Supply Chain Optimization, and Pharmacovigilance), Component (Services and Software), End-User (Pharmaceutical & BioComponent Companies, Medical Device Companies, Research Centres and Third-party Administrators), Delivery Model (On-premise model and On-demand model) and Geography – Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026
Life science involves the study of living organisms. This study of life science includes all branches of science, such as zoology, botany, biology, and other sciences. Life science is the study that provides a significant perception of the different disease procedures and enables them to discover the therapies and medical equipment. Life science analytics is the software used to take advantage of the study to bring growth in global collaboration based on the grounds of accurate clinical information. The rise in the life science analytics market growth can be ascribed to factors such as the increasing volume of data in the life science industry, requirement of data normalization, and the rising burden of cutting healthcare expenses. But, data security issues may hinder the market growth. Life Science Analytics Market is predicted to grow at a CAGR of 10.80% with a market value of $42.23 billion in 2026.
Research Methodology:
The recycled plastics market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:
Life Science Analytics market scope
Type: Market Size & Analysis
Further, the life science analytics market is further segmented into the application market. In the application market, the sales and marketing applications can be predicted to have the largest share in the market growth. This growth is due to the increasing deployment of life science analytics in the life science firm to conduct the sales and marketing promotion and also the growing preference of after marketing survey.
Moving on to the component segment in the life science analytics market is segregated into services and software. The service component has held the largest share due to the rising burden of reducing costs in healthcare and for the invention of advanced treatments in less time.
Life science analytics market based on end-user, the pharmaceutical and biocomponent companies, are the most life science analytics utilizing end-users because of the wide usage of the analytics in the sales and marketing by pharmaceutical company and usage of solutions gained by the analytics in biocomponent company.
Then the life science analytics market is segmented on the bases of the delivery model. The delivery model segment is divided into on-premise and on-demand. The on-demand delivery model has held the largest demand share due to the user-friendly feature of this delivery model.
Geographically, North America accounted for the largest share due to rapidly increasing diseases due to the increase in the geriatric population, potential economy, and growing expenditure on research and development are factors driving life science analytics the market growth. Moreover, the unhealthy lifestyle of people in this region is supporting market growth.
The global life science analytics the market is rapidly penetrating its position all over the world with its authentic features. The comprehensive analysis of the global driving insights of the market includes the globally increased advanced technology, evolution of social media & its effect on life science, and also the requirement of better outcomes of patients.
SAS Institute Inc, IBM Corporation, Oracle Corporation, Iqvia, Accenture, Maxisit, Cognizant, Scio Health Analytics, Take Solutions, Wipro Limited, and 3DHISTECH, SAP SE. This is the list of few market competitors who are commanding the life science analytics the market.
Therefore, the life science analytics market is playing an important role in the healthcare sector by enhancing clinical trials and improving disease analysis. The life science analytics market study provides the market insights of drivers, challenges, and company strategies.
Research Methodology:
The recycled plastics market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:
Life Science Analytics market scope
Type: Market Size & Analysis
- Descriptive Analytics
- Predictive Analytics
- Prescriptive Analytics
- Research & Development
- Clinical Trials
- Sales & Marketing
- Supply Chain Optimization
- Pharmacovigilance
- Services
- Software
- Pharmaceutical & BioComponent Companies
- Medical Device Companies
- Research Centres
- Third-party Administrators
- On-premise model
- On-demand model
- North America
- Europe
- Asia Pacific
- Rest of the World
Further, the life science analytics market is further segmented into the application market. In the application market, the sales and marketing applications can be predicted to have the largest share in the market growth. This growth is due to the increasing deployment of life science analytics in the life science firm to conduct the sales and marketing promotion and also the growing preference of after marketing survey.
Moving on to the component segment in the life science analytics market is segregated into services and software. The service component has held the largest share due to the rising burden of reducing costs in healthcare and for the invention of advanced treatments in less time.
Life science analytics market based on end-user, the pharmaceutical and biocomponent companies, are the most life science analytics utilizing end-users because of the wide usage of the analytics in the sales and marketing by pharmaceutical company and usage of solutions gained by the analytics in biocomponent company.
Then the life science analytics market is segmented on the bases of the delivery model. The delivery model segment is divided into on-premise and on-demand. The on-demand delivery model has held the largest demand share due to the user-friendly feature of this delivery model.
Geographically, North America accounted for the largest share due to rapidly increasing diseases due to the increase in the geriatric population, potential economy, and growing expenditure on research and development are factors driving life science analytics the market growth. Moreover, the unhealthy lifestyle of people in this region is supporting market growth.
The global life science analytics the market is rapidly penetrating its position all over the world with its authentic features. The comprehensive analysis of the global driving insights of the market includes the globally increased advanced technology, evolution of social media & its effect on life science, and also the requirement of better outcomes of patients.
SAS Institute Inc, IBM Corporation, Oracle Corporation, Iqvia, Accenture, Maxisit, Cognizant, Scio Health Analytics, Take Solutions, Wipro Limited, and 3DHISTECH, SAP SE. This is the list of few market competitors who are commanding the life science analytics the market.
Therefore, the life science analytics market is playing an important role in the healthcare sector by enhancing clinical trials and improving disease analysis. The life science analytics market study provides the market insights of drivers, challenges, and company strategies.
- The life science analytics market study gives a substantial analysis of the market segmentation based on the various aspects.
- This study presents an extensive analysis of geographical regions to ascertain the emerging opportunity from the entire world.
- This study involves the complete quantitative analysis of the present market and estimations to recognize market opportunities.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. TYPE: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Descriptive Analytics
5.3. Predictive Analytics
5.4. Prescriptive Analytics
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Research & Development
6.3. Clinical Trials
6.4. Sales & Marketing
6.5. Supply Chain Optimization
6.6. Pharmacovigilance
7. COMPONENT: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Services
7.3. Software
8. END USER: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. Pharmaceutical & BioComponent Companies
8.3. Medical Device Companies
8.4. Research Centers
8.5. Third-party Administrators
9. DELIVERY MODEL: MARKET SIZE & ANALYSIS
9.1. Overview
9.2. On-premise model
9.3. On-demand model
10. GEOGRAPHY: MARKET SIZE & ANALYSIS
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia Pacific
10.5. Rest of the World
11. COMPETITIVE LANDSCAPE
11.1. Competitor Comparison Analysis
11.2. Market Developments
11.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
11.2.2. Product Launches and execution
12. VENDOR PROFILES
12.1. SAS Institute Inc.
12.1.1. Overview
12.1.2. Product Offerings
12.1.3. Geographic Revenue
12.1.4. Business Units
12.1.5. Developments
12.1.6. Business Strategy
12.2. IBM Corporation
12.2.1. Overview
12.2.2. Product Offerings
12.2.3. Geographic Revenue
12.2.4. Business Units
12.2.5. Developments
12.2.6. Business Strategy
12.3. Oracle Corporation
12.3.1. Overview
12.3.2. Product Offerings
12.3.3. Geographic Revenue
12.3.4. Business Units
12.3.5. Developments
12.3.6. Business Strategy
12.4. Iqvia
12.4.1. Overview
12.4.2. Product Offerings
12.4.3. Geographic Revenue
12.4.4. Business Units
12.4.5. Developments
12.4.6. Business Strategy
12.5. Accenture
12.5.1. Overview
12.5.2. Product Offerings
12.5.3. Geographic Revenue
12.5.4. Business Units
12.5.5. Developments
12.5.6. Business Strategy
12.6. Cognizant
12.6.1. Overview
12.6.2. Product Offerings
12.6.3. Geographic Revenue
12.6.4. Business Units
12.6.5. Developments
12.6.6. Business Strategy
12.7. Maxisit
12.7.1. Overview
12.7.2. Product Offerings
12.7.3. Geographic Revenue
12.7.4. Business Units
12.7.5. Developments
12.7.6. Business Strategy
12.8. Scio Health Analytics
12.8.1. Overview
12.8.2. Product Offerings
12.8.3. Geographic Revenue
12.8.4. Business Units
12.8.5. Developments
12.8.6. Business Strategy
12.9. Take Solutions
12.9.1. Overview
12.9.2. Product Offerings
12.9.3. Geographic Revenue
12.9.4. Business Units
12.9.5. Developments
12.9.6. Business Strategy
12.10. Wipro Limited
12.10.1. Overview
12.10.2. Product Offerings
12.10.3. Geographic Revenue
12.10.4. Business Units
12.10.5. Developments
12.10.6. Business Strategy
13. COMPANIES TO WATCH
13.1. 3DHISTECH
13.1.1. Overview
13.1.2. Market
13.1.3. Business Strategy
13.2. SAP SE.
13.2.1. Overview
13.2.2. Market
13.2.3. Business Strategy
14. ANALYST OPINION
15. ANNEXURE
15.1. Report Scope
15.2. Market Definitions
15.3. Research Methodology
15.3.1. Data Collation and In-house Estimation
15.3.2. Market Triangulation
15.3.3. Forecasting
15.4. Report Assumptions
15.5. Declarations
15.6. Stakeholders
15.7. Abbreviations
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. TYPE: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Descriptive Analytics
5.3. Predictive Analytics
5.4. Prescriptive Analytics
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Research & Development
6.3. Clinical Trials
6.4. Sales & Marketing
6.5. Supply Chain Optimization
6.6. Pharmacovigilance
7. COMPONENT: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Services
7.3. Software
8. END USER: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. Pharmaceutical & BioComponent Companies
8.3. Medical Device Companies
8.4. Research Centers
8.5. Third-party Administrators
9. DELIVERY MODEL: MARKET SIZE & ANALYSIS
9.1. Overview
9.2. On-premise model
9.3. On-demand model
10. GEOGRAPHY: MARKET SIZE & ANALYSIS
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia Pacific
10.5. Rest of the World
11. COMPETITIVE LANDSCAPE
11.1. Competitor Comparison Analysis
11.2. Market Developments
11.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
11.2.2. Product Launches and execution
12. VENDOR PROFILES
12.1. SAS Institute Inc.
12.1.1. Overview
12.1.2. Product Offerings
12.1.3. Geographic Revenue
12.1.4. Business Units
12.1.5. Developments
12.1.6. Business Strategy
12.2. IBM Corporation
12.2.1. Overview
12.2.2. Product Offerings
12.2.3. Geographic Revenue
12.2.4. Business Units
12.2.5. Developments
12.2.6. Business Strategy
12.3. Oracle Corporation
12.3.1. Overview
12.3.2. Product Offerings
12.3.3. Geographic Revenue
12.3.4. Business Units
12.3.5. Developments
12.3.6. Business Strategy
12.4. Iqvia
12.4.1. Overview
12.4.2. Product Offerings
12.4.3. Geographic Revenue
12.4.4. Business Units
12.4.5. Developments
12.4.6. Business Strategy
12.5. Accenture
12.5.1. Overview
12.5.2. Product Offerings
12.5.3. Geographic Revenue
12.5.4. Business Units
12.5.5. Developments
12.5.6. Business Strategy
12.6. Cognizant
12.6.1. Overview
12.6.2. Product Offerings
12.6.3. Geographic Revenue
12.6.4. Business Units
12.6.5. Developments
12.6.6. Business Strategy
12.7. Maxisit
12.7.1. Overview
12.7.2. Product Offerings
12.7.3. Geographic Revenue
12.7.4. Business Units
12.7.5. Developments
12.7.6. Business Strategy
12.8. Scio Health Analytics
12.8.1. Overview
12.8.2. Product Offerings
12.8.3. Geographic Revenue
12.8.4. Business Units
12.8.5. Developments
12.8.6. Business Strategy
12.9. Take Solutions
12.9.1. Overview
12.9.2. Product Offerings
12.9.3. Geographic Revenue
12.9.4. Business Units
12.9.5. Developments
12.9.6. Business Strategy
12.10. Wipro Limited
12.10.1. Overview
12.10.2. Product Offerings
12.10.3. Geographic Revenue
12.10.4. Business Units
12.10.5. Developments
12.10.6. Business Strategy
13. COMPANIES TO WATCH
13.1. 3DHISTECH
13.1.1. Overview
13.1.2. Market
13.1.3. Business Strategy
13.2. SAP SE.
13.2.1. Overview
13.2.2. Market
13.2.3. Business Strategy
14. ANALYST OPINION
15. ANNEXURE
15.1. Report Scope
15.2. Market Definitions
15.3. Research Methodology
15.3.1. Data Collation and In-house Estimation
15.3.2. Market Triangulation
15.3.3. Forecasting
15.4. Report Assumptions
15.5. Declarations
15.6. Stakeholders
15.7. Abbreviations
LIST OF TABLES
TABLE 1. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 2. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR DESCRIPTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PREDICTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 4. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PRESCRIPTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 5. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 6. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR RESEARCH & DEVELOPMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 7. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PRECLINICAL TRIALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 8. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR CLINICAL TRIALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SALES & MARKETING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR REGULATORY COMPLIANCE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 11. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SUPPLY CHAIN OPTIMIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PHARMACOVIGILANCE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 14. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 15. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 16. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 17. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PHARMACEUTICAL & BIOCOMPONENT COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 18. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR MEDICAL DEVICE COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 19. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR RESEARCH CENTERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 20. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR THIRD-PARTY ADMINISTRATORS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 21. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR DELIVERY MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 22. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR ON PREMISE MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 23. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR ON DEMAND MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 24. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 25. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 26. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 27. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 28. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 29. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 30. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 31. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 32. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 33. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 34. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 35. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 36. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 37. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 38. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 39. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 40. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 41. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 42. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 43. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 44. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 45. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 46. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 47. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 48. SAS INSTITUTE INC.: OVERVIEW
TABLE 49. SAS INSTITUTE INC.: STRATEGIC SNAPSHOT
TABLE 50. SAS INSTITUTE INC.: BUSINESS FOCUS
TABLE 51. SAS INSTITUTE INC.: COMPONENT/SERVICE PORTFOLIO
TABLE 52. IBM CORPORATION: OVERVIEW
TABLE 53. IBM CORPORATION: STRATEGIC SNAPSHOT
TABLE 54. IBM CORPORATION: BUSINESS FOCUS
TABLE 55. IBM CORPORATION: COMPONENT/SERVICE PORTFOLIO
TABLE 56. ORACLE CORPORATION: OVERVIEW
TABLE 57. ORACLE CORPORATION: STRATEGIC SNAPSHOT
TABLE 58. ORACLE CORPORATION: BUSINESS FOCUS
TABLE 59. ORACLE CORPORATION: COMPONENT/SERVICE PORTFOLIO
TABLE 60. IQVIA .: OVERVIEW
TABLE 61. IQVIA .: STRATEGIC SNAPSHOT
TABLE 62. IQVIA .: BUSINESS FOCUS
TABLE 63. IQVIA .: COMPONENT/SERVICE PORTFOLIO
TABLE 64. ACCENTURE: OVERVIEW
TABLE 65. ACCENTURE: STRATEGIC SNAPSHOT
TABLE 66. ACCENTURE: BUSINESS FOCUS
TABLE 67. ACCENTURE: COMPONENT/SERVICE PORTFOLIO
TABLE 68. CHOICESPINE: OVERVIEW
TABLE 69. CHOICESPINE: STRATEGIC SNAPSHOT
TABLE 70. CHOICESPINE: BUSINESS FOCUS
TABLE 71. CHOICESPINE: COMPONENT/SERVICE PORTFOLIO
TABLE 72. MAXISIT: OVERVIEW
TABLE 73. MAXISIT: STRATEGIC SNAPSHOT
TABLE 74. MAXISIT: BUSINESS FOCUS
TABLE 75. MAXISIT: COMPONENT/SERVICE PORTFOLIO
TABLE 76. SCIO HEALTH ANALYTICS: OVERVIEW
TABLE 77. SCIO HEALTH ANALYTICS: STRATEGIC SNAPSHOT
TABLE 78. SCIO HEALTH ANALYTICS: BUSINESS FOCUS
TABLE 79. SCIO HEALTH ANALYTICS: COMPONENT/SERVICE PORTFOLIO
TABLE 80. TAKE SOLUTIONS: OVERVIEW
TABLE 81. TAKE SOLUTIONS: STRATEGIC SNAPSHOT
TABLE 82. TAKE SOLUTIONS: BUSINESS FOCUS
TABLE 83. TAKE SOLUTIONS: COMPONENT/SERVICE PORTFOLIO
TABLE 84. WIPRO LIMITED: OVERVIEW
TABLE 85. WIPRO LIMITED: STRATEGIC SNAPSHOT
TABLE 86. WIPRO LIMITED: BUSINESS FOCUS
TABLE 87. WIPRO LIMITED: COMPONENT/SERVICE PORTFOLIO
TABLE 1. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 2. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR DESCRIPTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PREDICTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 4. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PRESCRIPTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 5. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 6. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR RESEARCH & DEVELOPMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 7. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PRECLINICAL TRIALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 8. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR CLINICAL TRIALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SALES & MARKETING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR REGULATORY COMPLIANCE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 11. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SUPPLY CHAIN OPTIMIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PHARMACOVIGILANCE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 14. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 15. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 16. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 17. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PHARMACEUTICAL & BIOCOMPONENT COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 18. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR MEDICAL DEVICE COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 19. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR RESEARCH CENTERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 20. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR THIRD-PARTY ADMINISTRATORS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 21. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR DELIVERY MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 22. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR ON PREMISE MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 23. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR ON DEMAND MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 24. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 25. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 26. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 27. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 28. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 29. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 30. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 31. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 32. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 33. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 34. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 35. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 36. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 37. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 38. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 39. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 40. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 41. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 42. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 43. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 44. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 45. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 46. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 47. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 48. SAS INSTITUTE INC.: OVERVIEW
TABLE 49. SAS INSTITUTE INC.: STRATEGIC SNAPSHOT
TABLE 50. SAS INSTITUTE INC.: BUSINESS FOCUS
TABLE 51. SAS INSTITUTE INC.: COMPONENT/SERVICE PORTFOLIO
TABLE 52. IBM CORPORATION: OVERVIEW
TABLE 53. IBM CORPORATION: STRATEGIC SNAPSHOT
TABLE 54. IBM CORPORATION: BUSINESS FOCUS
TABLE 55. IBM CORPORATION: COMPONENT/SERVICE PORTFOLIO
TABLE 56. ORACLE CORPORATION: OVERVIEW
TABLE 57. ORACLE CORPORATION: STRATEGIC SNAPSHOT
TABLE 58. ORACLE CORPORATION: BUSINESS FOCUS
TABLE 59. ORACLE CORPORATION: COMPONENT/SERVICE PORTFOLIO
TABLE 60. IQVIA .: OVERVIEW
TABLE 61. IQVIA .: STRATEGIC SNAPSHOT
TABLE 62. IQVIA .: BUSINESS FOCUS
TABLE 63. IQVIA .: COMPONENT/SERVICE PORTFOLIO
TABLE 64. ACCENTURE: OVERVIEW
TABLE 65. ACCENTURE: STRATEGIC SNAPSHOT
TABLE 66. ACCENTURE: BUSINESS FOCUS
TABLE 67. ACCENTURE: COMPONENT/SERVICE PORTFOLIO
TABLE 68. CHOICESPINE: OVERVIEW
TABLE 69. CHOICESPINE: STRATEGIC SNAPSHOT
TABLE 70. CHOICESPINE: BUSINESS FOCUS
TABLE 71. CHOICESPINE: COMPONENT/SERVICE PORTFOLIO
TABLE 72. MAXISIT: OVERVIEW
TABLE 73. MAXISIT: STRATEGIC SNAPSHOT
TABLE 74. MAXISIT: BUSINESS FOCUS
TABLE 75. MAXISIT: COMPONENT/SERVICE PORTFOLIO
TABLE 76. SCIO HEALTH ANALYTICS: OVERVIEW
TABLE 77. SCIO HEALTH ANALYTICS: STRATEGIC SNAPSHOT
TABLE 78. SCIO HEALTH ANALYTICS: BUSINESS FOCUS
TABLE 79. SCIO HEALTH ANALYTICS: COMPONENT/SERVICE PORTFOLIO
TABLE 80. TAKE SOLUTIONS: OVERVIEW
TABLE 81. TAKE SOLUTIONS: STRATEGIC SNAPSHOT
TABLE 82. TAKE SOLUTIONS: BUSINESS FOCUS
TABLE 83. TAKE SOLUTIONS: COMPONENT/SERVICE PORTFOLIO
TABLE 84. WIPRO LIMITED: OVERVIEW
TABLE 85. WIPRO LIMITED: STRATEGIC SNAPSHOT
TABLE 86. WIPRO LIMITED: BUSINESS FOCUS
TABLE 87. WIPRO LIMITED: COMPONENT/SERVICE PORTFOLIO
LIST OF FIGURES
CHART. 1. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
CHART. 2. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR DESCRIPTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 3. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PREDICTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 4. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PRESCRIPTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 5. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 6. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR RESEARCH & DEVELOPMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 7. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PRECLINICAL TRIALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 8. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR CLINICAL TRIALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 9. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SALES & MARKETING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 10. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR REGULATORY COMPLIANCE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 11. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SUPPLY CHAIN OPTIMIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 12. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PHARMACOVIGILANCE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 13. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
CHART. 14. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 15. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 16. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 17. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PHARMACEUTICAL & BIOCOMPONENT COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 18. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR MEDICAL DEVICE COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 19. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR RESEARCH CENTERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 20. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR THIRD-PARTY ADMINISTRATORS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 21. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR DELIVERY MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 22. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR ON PREMISE MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 23. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR ON DEMAND MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 24. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 25. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
CHART. 26. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 27. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
CHART. 28. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 29. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
CHART. 30. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 31. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
CHART. 32. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 33. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
CHART. 34. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 35. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
CHART. 36. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 37. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
CHART. 38. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 39. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
CHART. 40. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 41. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
CHART. 42. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 43. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
CHART. 44. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 45. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
CHART. 46. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 47. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
CHART. 1. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
CHART. 2. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR DESCRIPTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 3. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PREDICTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 4. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PRESCRIPTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 5. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 6. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR RESEARCH & DEVELOPMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 7. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PRECLINICAL TRIALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 8. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR CLINICAL TRIALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 9. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SALES & MARKETING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 10. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR REGULATORY COMPLIANCE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 11. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SUPPLY CHAIN OPTIMIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 12. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PHARMACOVIGILANCE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 13. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
CHART. 14. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 15. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 16. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 17. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PHARMACEUTICAL & BIOCOMPONENT COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 18. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR MEDICAL DEVICE COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 19. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR RESEARCH CENTERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 20. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR THIRD-PARTY ADMINISTRATORS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 21. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR DELIVERY MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 22. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR ON PREMISE MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 23. GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR ON DEMAND MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 24. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 25. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
CHART. 26. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 27. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
CHART. 28. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 29. NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
CHART. 30. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 31. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
CHART. 32. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 33. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
CHART. 34. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 35. EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
CHART. 36. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 37. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
CHART. 38. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 39. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
CHART. 40. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 41. ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
CHART. 42. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 43. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
CHART. 44. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 45. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
CHART. 46. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
CHART. 47. REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
